Pay-For-Delay, REMS Reform Legislation Making (Slow) Progress In House

CREATES Act gets a hearing, but Judiciary committee members spend much of their time asking questions about basic concepts of FDA review.

Capitol House

More from Generics

More from Biosimilars & Generics